These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 11696976)
21. Sequence and characterisation of the RET proto-oncogene 5' flanking region: analysis of retinoic acid responsiveness at the transcriptional level. Patrone G; Puliti A; Bocciardi R; Ravazzolo R; Romeo G FEBS Lett; 1997 Dec; 419(1):76-82. PubMed ID: 9426223 [TBL] [Abstract][Full Text] [Related]
22. The Drosophila Ret gene is transcribed in multiple alternatively spliced forms. Huen DS; Elsdon M; Ponder BA Mol Gen Genet; 2000 Oct; 264(3):335-40. PubMed ID: 11085274 [TBL] [Abstract][Full Text] [Related]
23. Diversity of RET proto-oncogene mutations in familial and sporadic Hirschsprung disease. Attié T; Pelet A; Edery P; Eng C; Mulligan LM; Amiel J; Boutrand L; Beldjord C; Nihoul-Fékété C; Munnich A Hum Mol Genet; 1995 Aug; 4(8):1381-6. PubMed ID: 7581377 [TBL] [Abstract][Full Text] [Related]
24. Isolation and characterization of a chicken homolog of the c-ret proto-oncogene. Schuchardt A; Srinivas S; Pachnis V; Costantini F Oncogene; 1995 Feb; 10(4):641-9. PubMed ID: 7862441 [TBL] [Abstract][Full Text] [Related]
25. RET proto-oncogene mutations in inherited and sporadic medullary thyroid cancer. Blaugrund JE; Johns MM; Eby YJ; Ball DW; Baylin SB; Hruban RH; Sidransky D Hum Mol Genet; 1994 Oct; 3(10):1895-7. PubMed ID: 7849720 [No Abstract] [Full Text] [Related]
26. High prevalence of the C634Y mutation in the RET proto-oncogene in MEN 2A families in Spain. Sánchez B; Robledo M; Biarnes J; Sáez ME; Volpini V; Benítez J; Navarro E; Ruiz A; Antiñolo G; Borrego S J Med Genet; 1999 Jan; 36(1):68-70. PubMed ID: 9950371 [TBL] [Abstract][Full Text] [Related]
27. A single missense mutation in codon 918 of the RET proto-oncogene in sporadic medullary thyroid carcinomas. Maeda S; Namba H; Takamura N; Tanigawa K; Takahashi M; Noguchi S; Nagataki S; Kanematsu T; Yamashita S Endocr J; 1995 Apr; 42(2):245-50. PubMed ID: 7627269 [TBL] [Abstract][Full Text] [Related]
28. Somatic mutations of the RET proto-oncogene are not required for tumor development in multiple endocrine neoplasia type 2 (MEN 2) gene carriers. Landsvater RM; de Wit MJ; Zewald RA; Hofstra RM; Buys CH; Ploos van Amstel HK; Höppener JW; Lips CJ Cancer Res; 1996 Nov; 56(21):4853-5. PubMed ID: 8895732 [TBL] [Abstract][Full Text] [Related]
29. RET proto-oncogene point mutations in sporadic neuroendocrine tumors. Komminoth P; Roth J; Muletta-Feurer S; Saremaslani P; Seelentag WK; Heitz PU J Clin Endocrinol Metab; 1996 Jun; 81(6):2041-6. PubMed ID: 8964826 [TBL] [Abstract][Full Text] [Related]
30. Conservation of RET proto-oncogene splicing variants and implications for RET isoform function. Carter MT; Yome JL; Marcil MN; Martin CA; Vanhorne JB; Mulligan LM Cytogenet Cell Genet; 2001; 95(3-4):169-76. PubMed ID: 12063395 [TBL] [Abstract][Full Text] [Related]
31. Identification of multiple endocrine neoplasia, type 2 gene carriers using linkage analysis and analysis of the RET proto-oncogene. Tsai MS; Ledger GA; Khosla S; Gharib H; Thibodeau SN J Clin Endocrinol Metab; 1994 May; 78(5):1261-4. PubMed ID: 7909818 [TBL] [Abstract][Full Text] [Related]
32. Germline RET proto-oncogene mutations in two Taiwanese families with multiple endocrine neoplasia type 2A. Wu SL; Chang TC; Huang CN; Chuang LM; Chang TJ J Formos Med Assoc; 1998 Sep; 97(9):614-8. PubMed ID: 9795529 [TBL] [Abstract][Full Text] [Related]
33. Cloning and characterization of H4 (D10S170), a gene involved in RET rearrangements in vivo. Grieco M; Cerrato A; Santoro M; Fusco A; Melillo RM; Vecchio G Oncogene; 1994 Sep; 9(9):2531-5. PubMed ID: 8058316 [TBL] [Abstract][Full Text] [Related]
34. Breakpoint characterization of the ret/PTC oncogene in human papillary thyroid carcinoma. Smanik PA; Furminger TL; Mazzaferri EL; Jhiang SM Hum Mol Genet; 1995 Dec; 4(12):2313-8. PubMed ID: 8634704 [TBL] [Abstract][Full Text] [Related]
35. Germ line mutations of the ret proto-oncogene in Japanese patients with multiple endocrine neoplasia type 2A and type 2B. Maruyama S; Iwashita T; Imai T; Funahashi H; Ceccherini I; Luo Y; Romeo G; Matsuo S; Matsuyama M; Takahashi M Jpn J Cancer Res; 1994 Sep; 85(9):879-82. PubMed ID: 7961113 [TBL] [Abstract][Full Text] [Related]
36. Characterization of the promoter region and oligomerization domain of H4 (D10S170), a gene frequently rearranged with the ret proto-oncogene. Tong Q; Li Y; Smanik PA; Fithian LJ; Xing S; Mazzaferri EL; Jhiang SM Oncogene; 1995 May; 10(9):1781-7. PubMed ID: 7753554 [TBL] [Abstract][Full Text] [Related]
37. Cloning of an activated human ret gene with a novel 5' sequence fused by DNA rearrangement. Kunieda T; Matsui M; Nomura N; Ishizaki R Gene; 1991 Nov; 107(2):323-8. PubMed ID: 1748302 [TBL] [Abstract][Full Text] [Related]
38. A homozygous missense mutation in the tyrosine E kinase domain of the RET proto-oncogene in an infant with total intestinal aganglionosis. Shimotake T; Go S; Inoue K; Tomiyama H; Iwai N Am J Gastroenterol; 2001 Apr; 96(4):1286-91. PubMed ID: 11316186 [TBL] [Abstract][Full Text] [Related]
39. Characterization of RET proto-oncogene 3' splicing variants and polyadenylation sites: a novel C-terminus for RET. Myers SM; Eng C; Ponder BA; Mulligan LM Oncogene; 1995 Nov; 11(10):2039-45. PubMed ID: 7478523 [TBL] [Abstract][Full Text] [Related]
40. Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas. Komminoth P Verh Dtsch Ges Pathol; 1995; 79():L-LV. PubMed ID: 8600671 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]